The WE Pilot Study: Walking Epidurals

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 14, 2019

Primary Completion Date

March 22, 2019

Study Completion Date

March 22, 2019

Conditions
Labor Pain
Interventions
OTHER

Walking epidural

Parturients in spontaneous or induced labor will receive combined spinal-epidural analgesia (CSE) using an infusion of bupivacaine 0.0625% and fentanyl 2 mcg/mL and will be encouraged to walk a minimum of 15 minutes every hour during the first stage of labor.

Trial Locations (1)

H2X 3E4

Centre Hospitalier de l'Université de Montréal (CHUM), Montreal

All Listed Sponsors
lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER

NCT03710382 - The WE Pilot Study: Walking Epidurals | Biotech Hunter | Biotech Hunter